🇺🇸 FDA
Pipeline program

VCH-759 (BCH-27759)

VCH759-201

Phase 2 small_molecule completed

Quick answer

VCH-759 (BCH-27759) for Hepatitis C, Chronic is a Phase 2 program (small_molecule) at Vertex Pharmaceuticals (Ireland) Limited with 1 ClinicalTrials.gov record(s).

Program details

Company
Vertex Pharmaceuticals (Ireland) Limited
Indication
Hepatitis C, Chronic
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials